{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:51:31Z","timestamp":1768683091382,"version":"3.49.0"},"reference-count":66,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00500","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T23:47:11Z","timestamp":1501112831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Giulia M.","family":"Camerino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejla","family":"Musaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Fonzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Barca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Camerino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Carrat\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Desaphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabata","family":"Pierno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","article-title":"Statin intolerance - an attempt at a unified definition. Position paper from an international lipid expert panel.","volume":"14","author":"Banach","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cge.12742","article-title":"Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.","volume":"90","author":"Barca","year":"2016","journal-title":"Clin. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nm.3918","article-title":"The central role of muscle stem cells in regenerative failure with aging.","volume":"21","author":"Blau","year":"2015","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.yexcr.2010.05.002","article-title":"Regulation of skeletal myogenesis by Notch.","volume":"316","author":"Buas","year":"2010","journal-title":"Exp. Cell Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00424-014-1495-1","article-title":"Protein kinase C theta (PKC\u03b8) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKC\u03b8.","volume":"466","author":"Camerino","year":"","journal-title":"Pflugers Arch."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/hmg\/ddu287","article-title":"Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.","volume":"23","author":"Camerino","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.taap.2016.06.032","article-title":"Statin-induced myotoxicity is exacerbated by aging: a biophysical and molecular biology study in rats treated with atorvastatin.","volume":"306","author":"Camerino","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129686","article-title":"Effects of nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation.","volume":"10","author":"Camerino","year":"2015","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.bcp.2011.01.022","article-title":"Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle.","volume":"81","author":"Camerino","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072028","article-title":"Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity.","volume":"8","author":"Camerino","year":"2013","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.5","article-title":"JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure.","volume":"3","author":"Chaanine","year":"2012","journal-title":"Cell Death Dis."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/srep10667","article-title":"The Cullin 4A\/B-DDB1-Cereblon E3 ubiquitin ligase complex mediates the degradation of CLC-1 chloride channels.","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4161\/cc.4.3.1518","article-title":"Aging, stem cells and tissue regeneration: lessons from muscle.","volume":"4","author":"Conboy","year":"2005","journal-title":"Cell Cycle"},{"key":"B15","doi-asserted-by":"publisher","first-page":"C634","DOI":"10.1152\/ajpcell.00372.2013","article-title":"Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.","volume":"307","author":"Cozzoli","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.","volume":"304","author":"De Luca","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.expneurol.2013.07.018","article-title":"Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes.","volume":"248","author":"Desaphy","year":"2013","journal-title":"Exp. Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040235","article-title":"Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle.","volume":"7","author":"Dinardo","year":"2012","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy.","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflugers Arch."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer.","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.5114\/aoms.2016.59938","article-title":"Molecular mechanisms of statin intolerance.","volume":"12","author":"Gluba-Brzozka","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128398","article-title":"Statin-induced increases in atrophy gene expression occur independently of changes in PGC1\u03b1 protein and mitochondrial content.","volume":"10","author":"Goodman","year":"2015","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.stem.2012.06.017","article-title":"The Par complex and integrins direct asymmetric cell division in adult intestinal stem cells.","volume":"11","author":"Goulas","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archinte.162.12.1329","article-title":"Statin therapy in older persons: pertinent issues.","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1172\/JCI32741","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity.","volume":"117","author":"Hanai","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.biocel.2013.06.029","article-title":"Calcineurin: a poorly understood regulator of muscle mass.","volume":"45","author":"Hudson","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1096\/fj.201500079R","article-title":"Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.","volume":"30","author":"Imbrici","year":"","journal-title":"FASEB J."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00121","article-title":"Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery.","volume":"7","author":"Imbrici","year":"","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia.","volume":"257","author":"Koch","year":"1992","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1124\/jpet.106.118331","article-title":"Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum\/mitochondria Ca2+-release system.","volume":"321","author":"Liantonio","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1091\/mbc.E10-10-0821","article-title":"PKC\u03b8 signaling is required for myoblast fusion by regulating the expression of caveolin-3 and \u03b21D integrin upstream focal adhesion kinase.","volume":"22","author":"Madaro","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4103\/2230-8210.113754","article-title":"Safety of statins.","volume":"17","author":"Maji","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1113\/jphysiol.2012.238022","article-title":"Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.","volume":"590","author":"Mallinson","year":"2012","journal-title":"J. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy.","volume":"587","author":"Mallinson","year":"2009","journal-title":"J. Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1042\/BST20140207","article-title":"Targeting PKC\u03b8 in skeletal muscle and muscle diseases: good or bad?","volume":"42","author":"Marrocco","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"B36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2014.06.023","article-title":"Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes.","volume":"91","author":"Mele","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cell.2010.01.027","article-title":"Nfix regulates fetal-specific transcription in developing skeletal muscle.","volume":"140","author":"Messina","year":"2010","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drudis.2016.09.001","article-title":"Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?","volume":"22","author":"Muntean","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0955-0674(99)00036-8","article-title":"MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation.","volume":"11","author":"Naya","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/dbio.1995.0002","article-title":"Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors.","volume":"172","author":"Olson","year":"1995","journal-title":"Dev. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.expneurol.2004.07.018","article-title":"Regulated sarcolemmal localization of the muscle-specific ClC-1 chloride channel.","volume":"191","author":"Papponen","year":"2005","journal-title":"Exp. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1080\/14656566.2016.1197202","article-title":"Expert opinion: the therapeutic challenges faced by statin intolerance.","volume":"17","author":"Patel","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1085\/jgp.201611582","article-title":"Role of physiological ClC-1 Cl- ion channel regulation for the excitability and function of working skeletal muscle.","volume":"147","author":"Pedersen","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065167","article-title":"Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC\/mIgf-1 transgenic mice.","volume":"8","author":"Pierno","year":"2013","journal-title":"PLoS ONE"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1476-5381.2008.00079.x","article-title":"Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.","volume":"156","author":"Pierno","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1113\/jphysiol.2007.141358","article-title":"Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance.","volume":"584","author":"Pierno","year":"2007","journal-title":"J. Physiol."},{"key":"B47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bjp.0706917","article-title":"Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study.","volume":"149","author":"Pierno","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00726-011-1099-4","article-title":"Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat.","volume":"43","author":"Pierno","year":"2012","journal-title":"Amino Acids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11357-013-9544-9","article-title":"An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function.","volume":"36","author":"Pierno","year":"2014","journal-title":"Age (Dordr)."},{"key":"B50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12017-015-8356-8","article-title":"Clinical, molecular, and functional characterization of CLCN1 mutations in three families with recessive myotonia congenita.","volume":"17","author":"Portaro","year":"2015","journal-title":"Neuromolecular Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/humu.10063","article-title":"Myotonia caused by mutations in the muscle chloride channel gene ClCN1.","volume":"19","author":"Pusch","year":"2002","journal-title":"Hum. Mutat."},{"key":"B52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1152\/physrev.00038.2012","article-title":"Exercise, GLUT4, and skeletal muscle glucose uptake.","volume":"93","author":"Richter","year":"2013","journal-title":"Physiol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ptr.5003","volume":"28","author":"Shih","year":"2014","journal-title":"Momordica charantia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00249","article-title":"NOTCH1 can initiate NF-\u03baB activation via cytosolic interactions with components of the T Cell Signalosome.","volume":"5","author":"Shin","year":"2014","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1076-7460.2002.01422.x","article-title":"Rhabdomyolysis and statin therapy: relevance to the elderly.","volume":"11","author":"Sica","year":"2002","journal-title":"Am. J. Geriatr. Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.taap.2012.01.008","article-title":"Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins.","volume":"259","author":"Sirvent","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.trsl.2014.01.013","article-title":"Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.","volume":"164","author":"Taha","year":"2014","journal-title":"Transl. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2008.09.002","article-title":"Myotoxicity of lipid-lowering agents in a teenager with MELAS mutation.","volume":"39","author":"Tay","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067789","article-title":"Notch and PKC are involved in formation of the lateral region of the dorso-ventral axis in Drosophila embryos.","volume":"8","author":"Tremmel","year":"2013","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nmd.2007.07.009","article-title":"Reduced expression of Kir6.2\/SUR2A subunits explains KATP deficiency in K+-depleted rats.","volume":"18","author":"Tricarico","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.","volume":"25","author":"Urso","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1113\/expphysiol.2007.038190","article-title":"Isotonic contractile impairment due to genetic CLC-1 chloride channel deficiency in myotonic mouse diaphragm muscle.","volume":"92","author":"van Lunteren","year":"2007","journal-title":"Exp. Physiol."},{"key":"B63","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.CIR.0000139312.10076.BA","article-title":"Update on statins: 2003.","volume":"110","author":"Vaughan","year":"2004","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1172\/JCI15417","article-title":"Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice.","volume":"109","author":"Wu","year":"2002","journal-title":"J. Clin. Invest."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1093\/emboj\/20.22.6414","article-title":"Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.","volume":"20","author":"Wu","year":"2001","journal-title":"EMBO J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.toxlet.2013.10.037","article-title":"The role of NAD(+)-dependent isocitrate dehydrogenase 3 subunit \u03b1 in AFB1 induced liver lesion.","volume":"224","author":"Yang","year":"2014","journal-title":"Toxicol. Lett."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00500\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T23:47:16Z","timestamp":1501112836000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00500\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":66,"alternative-id":["10.3389\/fphar.2017.00500"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00500","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"500"}}